News

A. SPINI, G. ROBERTO, R. GINI, C. BARTOLINI, L. BAZZANI, S. DONNINI, S. CRISPINO, M. ZICHE. Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review. Neoplasma 2019; 66(6): 963–970 963, doi:10.4149/neo_2019_190110N34

Marie Christine Wulff Westergaard, Rikke Andersen, Chloé Chong, Julie Westerlin Kjeldsen, Magnus Pedersen, Christina Friese, Thomas Hasselager, Henrik Lajer, George Coukos, Michal Bassani-Sternberg, Marco Donia, Inge Marie Svane. Tumour-reactive T Cell Subsets in the Microenvironment of Ovarian Cancer. British Journal of Cancer. 2019 Feb;120(4):424-434. doi: 10.1038/s41416-019-0384-y. Epub 2019 Feb 5.

Tuyaerts, S., Rombauts, K., Everaert, T., Van Nuffel, AMT. and Amant, F. (2019). A Phase 2 Study to Assess the Immunomodulatory Capacity of a Lecithin-based Delivery System of Curcumin in Endometrial Cancer. Front. Nutr. 5:138. doi: 10.3389/fnut.2018.00138

In December 2017, ACF reworked its website aimed at medical professionals and stakeholders. The updated site focusses on our mission, tools and project portfolio. For reasons of clarity, general information for patients (such as patient guides, educational articles on cancer treatments, new findings in cancer research, in the news, etc.) has been extracted from ACF’s reworked website. Instead, we will launch an additional website that is dedicated to patients only. This patient website will be a stand-alone with accessible content for patients, family members and community members. This website is scheduled for launch in early 2018. We hope you find all the information you need on the new site, and we welcome any feedback that you might have!